$NHC
NATIONAL HEALTHCARE CORP

2015 Q3 Form 10-Q Financial Statement

#000104733515000131 Filed on November 05, 2015

View on sec.gov

Income Statement

Concept 2015 Q3 2014 Q3
Revenue $225.4M $218.2M
YoY Change 3.28% 11.45%
Cost Of Revenue $135.1M $128.9M
YoY Change 4.81% 13.37%
Gross Profit $90.30M $89.30M
YoY Change 1.12% 8.9%
Gross Profit Margin 40.06% 40.92%
Selling, General & Admin $10.00M $9.900M
YoY Change 1.01% 0.0%
% of Gross Profit 11.07% 11.09%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $9.200M $8.600M
YoY Change 6.98% 21.13%
% of Gross Profit 10.19% 9.63%
Operating Expenses $75.90M $74.00M
YoY Change 2.57% 17.83%
Operating Profit $13.76M $14.74M
YoY Change -6.62% -23.25%
Interest Expense $594.0K $632.0K
YoY Change -6.01% -88.71%
% of Operating Profit 4.32% 4.29%
Other Income/Expense, Net $4.550M $3.937M
YoY Change 15.57% -55408349165492740.0%
Pretax Income $18.31M $18.67M
YoY Change -1.94% -38.58%
Income Tax $5.744M $5.844M
% Of Pretax Income 31.37% 31.3%
Net Earnings $12.57M $12.83M
YoY Change -2.04% -35.53%
Net Earnings / Revenue 5.58% 5.88%
Basic Earnings Per Share $0.75 $0.77
Diluted Earnings Per Share $0.72 $0.75
COMMON SHARES
Basic Shares Outstanding 13.80M 13.81M
Diluted Shares Outstanding 14.42M 14.24M

Balance Sheet

Concept 2015 Q3 2014 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $181.3M $185.4M
YoY Change -2.21% -5.7%
Cash & Equivalents $70.78M $76.92M
Short-Term Investments $110.6M $108.5M
Other Short-Term Assets $29.30M $26.20M
YoY Change 11.83% -83.21%
Inventory $7.566M $7.400M
Prepaid Expenses
Receivables $81.85M $73.40M
Other Receivables $5.500M $6.400M
Total Short-Term Assets $305.6M $298.8M
YoY Change 2.27% -32.08%
LONG-TERM ASSETS
Property, Plant & Equipment $526.3M $507.4M
YoY Change 3.72% 11.54%
Goodwill $17.60M
YoY Change
Intangibles
YoY Change
Long-Term Investments $34.90M $35.20M
YoY Change -0.85% -2.49%
Other Assets $250.4M $171.3M
YoY Change 46.2% 1089.58%
Total Long-Term Assets $776.7M $744.2M
YoY Change 4.37% 38.82%
TOTAL ASSETS
Total Short-Term Assets $305.6M $298.8M
Total Long-Term Assets $776.7M $744.2M
Total Assets $1.082B $1.043B
YoY Change 3.77% 6.86%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.10M $13.60M
YoY Change 18.38% 8.8%
Accrued Expenses $86.00M $78.70M
YoY Change 9.28% -55.13%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $3.200M $3.000M
YoY Change 6.67%
Total Short-Term Liabilities $180.7M $166.3M
YoY Change 8.65% -35.01%
LONG-TERM LIABILITIES
Long-Term Debt $10.00M $44.30M
YoY Change -77.43% 343.0%
Other Long-Term Liabilities $16.74M $122.2M
YoY Change -86.3% 301.97%
Total Long-Term Liabilities $26.74M $166.5M
YoY Change -83.94% 312.13%
TOTAL LIABILITIES
Total Short-Term Liabilities $180.7M $166.3M
Total Long-Term Liabilities $26.74M $166.5M
Total Liabilities $207.4M $332.9M
YoY Change -37.69% 12.35%
SHAREHOLDERS EQUITY
Retained Earnings $359.4M
YoY Change
Common Stock $143.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $746.4M $710.1M
YoY Change
Total Liabilities & Shareholders Equity $1.082B $1.043B
YoY Change 3.77% 6.86%

Cashflow Statement

Concept 2015 Q3 2014 Q3
OPERATING ACTIVITIES
Net Income $12.57M $12.83M
YoY Change -2.04% -35.53%
Depreciation, Depletion And Amortization $9.200M $8.600M
YoY Change 6.98% 21.13%
Cash From Operating Activities $23.10M $30.90M
YoY Change -25.24% -28.31%
INVESTING ACTIVITIES
Capital Expenditures -$16.00M -$13.70M
YoY Change 16.79% -1.44%
Acquisitions
YoY Change
Other Investing Activities -$2.200M -$1.100M
YoY Change 100.0% -87.21%
Cash From Investing Activities -$18.10M -$14.90M
YoY Change 21.48% -33.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -5.800M -14.90M
YoY Change -61.07% 119.12%
NET CHANGE
Cash From Operating Activities 23.10M 30.90M
Cash From Investing Activities -18.10M -14.90M
Cash From Financing Activities -5.800M -14.90M
Net Change In Cash -800.0K 1.100M
YoY Change -172.73% -92.03%
FREE CASH FLOW
Cash From Operating Activities $23.10M $30.90M
Capital Expenditures -$16.00M -$13.70M
Free Cash Flow $39.10M $44.60M
YoY Change -12.33% -21.75%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
10839000
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1074552
nhc Annual Excess Coverage
AnnualExcessCoverage
7500000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Annual Excess Coverage
AnnualExcessCoverage
4000000
nhc Annual Excess Coverage
AnnualExcessCoverage
9000000
nhc Direct Business Coverage Statutory Limits
DirectBusinessCoverageStatutoryLimits
1000000
CY2015Q3 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1588000
CY2014Q3 nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
1392000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
5093000
nhc Dividends And Other Net Realized Gains And Losses On Sales Of Securities
DividendsAndOtherNetRealizedGainsAndLossesOnSalesOfSecurities
4350000
CY2015Q3 nhc Income Tax Benefit As A Percentage Of Income
IncomeTaxBenefitAsAPercentageOfIncome
0.094
CY2014Q3 nhc Income Tax Benefit As A Percentage Of Income
IncomeTaxBenefitAsAPercentageOfIncome
0.083
nhc Income Tax Benefit As A Percentage Of Income
IncomeTaxBenefitAsAPercentageOfIncome
0.029
nhc Income Tax Benefit As A Percentage Of Income
IncomeTaxBenefitAsAPercentageOfIncome
0.025
CY2015Q3 nhc Number Of Assisted Living Facilities
NumberOfAssistedLivingFacilities
19
CY2015Q3 nhc Number Of Beds
NumberOfBeds
9403
CY2015Q3 nhc Number Of Homecare Programs
NumberOfHomecarePrograms
36
CY2015Q3 nhc Number Of Independent Living Facilities
NumberOfIndependentLivingFacilities
5
CY2015Q3 nhc Number Of Nursing Facilities Under Medicaid Cost Report Audits
NumberOfNursingFacilitiesUnderMedicaidCostReportAudits
11
CY2015Q3 nhc Number Of Skilled Nursing Centers
NumberOfSkilledNursingCenters
74
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
585000
nhc Proceeds Payments Tax Benefit Expense From Stockbased Compensation
ProceedsPaymentsTaxBenefitExpenseFromStockbasedCompensation
201000
CY2015Q2 nhc Stock Repurchase Program Number Of Plans
StockRepurchaseProgramNumberOfPlans
2
CY2015Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
16107000
CY2014Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
15877000
CY2015Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
81854000
CY2015Q3 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
26411000
CY2014Q4 us-gaap Accounts Payable Other Current
AccountsPayableOtherCurrent
22931000
CY2015Q3 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3927000
CY2014Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
3927000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1557000
us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
1547000
CY2015Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
7142000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
78843000
CY2015Q3 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
59284000
CY2014Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
59859000
CY2015Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
329823000
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
307048000
CY2015Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
51020000
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
64608000
CY2015Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
166524000
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
154965000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
201000
us-gaap Adjustment To Additional Paid In Capital Income Tax Effect From Share Based Compensation Net
AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet
585000
CY2015Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
425000
CY2014Q3 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
377000
CY2014Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
5738000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
83542000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
79940000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsFairValue
84028000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
2588000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsAmortizedCost
4076000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
2593000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterTenYearsFairValue
4183000
CY2015Q3 us-gaap Assets
Assets
1082291000
CY2014Q4 us-gaap Assets
Assets
1074123000
CY2015Q3 us-gaap Assets Current
AssetsCurrent
305593000
CY2014Q4 us-gaap Assets Current
AssetsCurrent
322525000
CY2015Q3 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
362297000
CY2014Q4 us-gaap Assets Fair Value Disclosure
AssetsFairValueDisclosure
371226000
CY2015Q3 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
168483000
CY2014Q4 us-gaap Available For Sale Debt Securities Amortized Cost Basis
AvailableForSaleDebtSecuritiesAmortizedCostBasis
157642000
CY2015Q3 us-gaap Available For Sale Securities
AvailableForSaleSecurities
279391000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
290808000
CY2015Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
81966000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
103814000
CY2015Q3 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
1234000
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
824000
CY2015Q3 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
198659000
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
187818000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
69815000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsAmortizedCost
58863000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
69409000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities After Five Through Ten Years Fair Value
AvailableForSaleSecuritiesDebtMaturitiesAfterFiveThroughTenYearsFairValue
58872000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities After One Through Five Years Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesAfterOneThroughFiveYearsAmortizedCost
79240000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
168824000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Single Maturity Date
AvailableForSaleSecuritiesDebtMaturitiesSingleMaturityDate
158273000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
16840000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Amortized Cost
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearAmortizedCost
11161000
CY2015Q3 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
16882000
CY2014Q4 us-gaap Available For Sale Securities Debt Maturities Within One Year Fair Value
AvailableForSaleSecuritiesDebtMaturitiesWithinOneYearFairValue
11190000
CY2015Q3 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3230000
CY2014Q4 us-gaap Capital Lease Obligations Current
CapitalLeaseObligationsCurrent
3088000
CY2015Q3 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
31067000
CY2014Q4 us-gaap Capital Lease Obligations Noncurrent
CapitalLeaseObligationsNoncurrent
33508000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due
CapitalLeasesFutureMinimumPaymentsDue
43767000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
5200000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
5200000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
5200000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
5200000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
5200000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Due Thereafter
CapitalLeasesFutureMinimumPaymentsDueThereafter
17767000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Interest Included In Payments
CapitalLeasesFutureMinimumPaymentsInterestIncludedInPayments
9470000
CY2015Q3 us-gaap Capital Leases Future Minimum Payments Present Value Of Net Minimum Payments
CapitalLeasesFutureMinimumPaymentsPresentValueOfNetMinimumPayments
34297000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
69767000
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
81705000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
70781000
CY2014Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
76917000
CY2015Q3 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
70781000
CY2014Q4 us-gaap Cash And Cash Equivalents Fair Value Disclosure
CashAndCashEquivalentsFairValueDisclosure
69767000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1014000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-4788000
CY2015Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.40
CY2014Q3 us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
0.34
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1.14
us-gaap Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
1
CY2015Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
30000000
CY2015Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
14305185
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
1411085
CY2015Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
14305185
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
1411085
CY2015Q3 us-gaap Common Stock Value
CommonStockValue
143000
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
140000
CY2015Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
8472000
CY2014Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6883000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
24579000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
41946000
CY2014Q4 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3927000
CY2015Q3 us-gaap Continuing Care Retirement Communities Advance Fees Obligation For Future Services Amount
ContinuingCareRetirementCommunitiesAdvanceFeesObligationForFutureServicesAmount
3927000
CY2015Q3 us-gaap Costs And Expenses
CostsAndExpenses
211625000
CY2014Q3 us-gaap Costs And Expenses
CostsAndExpenses
203487000
us-gaap Costs And Expenses
CostsAndExpenses
625792000
us-gaap Costs And Expenses
CostsAndExpenses
597502000
CY2015Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
4129000
CY2014Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3359000
CY2015Q3 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
22168000
CY2014Q4 us-gaap Deferred Tax Assets Net Noncurrent
DeferredTaxAssetsNetNoncurrent
18700000
CY2015Q3 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
25510000
CY2014Q4 us-gaap Deferred Tax Liabilities Current
DeferredTaxLiabilitiesCurrent
35506000
CY2015Q3 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8392000
CY2014Q4 us-gaap Deposits Assets Noncurrent
DepositsAssetsNoncurrent
8791000
CY2015Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
9273000
CY2014Q3 us-gaap Depreciation And Amortization
DepreciationAndAmortization
8639000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
27442000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
25144000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
27442000
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
25144000
us-gaap Dividends Common Stock
DividendsCommonStock
14181000
us-gaap Dividends Common Stock
DividendsCommonStock
16256000
CY2015Q3 us-gaap Dividends Payable Current
DividendsPayableCurrent
7874000
CY2014Q4 us-gaap Dividends Payable Current
DividendsPayableCurrent
7000000
CY2015Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2152000
CY2014Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
2167000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
6487000
us-gaap Dividends Preferred Stock
DividendsPreferredStock
6502000
CY2015Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.75
CY2014Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.77
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.30
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
2.32
CY2015Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.72
CY2014Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.75
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.21
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
2.25
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
613173000
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
449000
us-gaap Gain Loss On Sale Of Securities Net
GainLossOnSaleOfSecuritiesNet
172000
CY2015Q3 us-gaap Goodwill
Goodwill
17600000
CY2015Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.314
CY2014Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.313
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.362
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.364
CY2015Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
699000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
6488000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
10272000
CY2014Q4 us-gaap Goodwill
Goodwill
17600000
CY2015Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
10035000
CY2014Q3 us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
10451000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
30850000
us-gaap Health Care Organization Other Revenue
HealthCareOrganizationOtherRevenue
32136000
CY2015Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
215351000
CY2014Q3 us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
207772000
us-gaap Health Care Organization Patient Service Revenue
HealthCareOrganizationPatientServiceRevenue
641845000
CY2015Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
225386000
CY2014Q3 us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
218223000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
672695000
us-gaap Health Care Organization Revenue
HealthCareOrganizationRevenue
645309000
CY2015Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
18311000
CY2014Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
18673000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
59805000
us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
60597000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
3924000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
5069000
CY2015Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1538000
CY2014Q3 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1414000
us-gaap Income Tax Examination Year Under Examination
IncomeTaxExaminationYearUnderExamination
2012
CY2015Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5744000
CY2014Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
5844000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21638000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
22028000
CY2015Q3 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
613000
CY2014Q4 us-gaap Income Taxes Receivable
IncomeTaxesReceivable
4727000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
230000
us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
557000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
8485000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1438000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-575000
us-gaap Increase Decrease In Accrued Salaries
IncreaseDecreaseInAccruedSalaries
-9039000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-11000
us-gaap Increase Decrease In Customer Deposits
IncreaseDecreaseInCustomerDeposits
-400000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4795000
us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
4517000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
770000
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
759000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
486000
us-gaap Increase Decrease In Deposits
IncreaseDecreaseInDeposits
-248000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
-4114000
us-gaap Increase Decrease In Income Taxes Receivable
IncreaseDecreaseInIncomeTaxesReceivable
5953000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
439000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
216000
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
3480000
us-gaap Increase Decrease In Other Accounts Payable
IncreaseDecreaseInOtherAccountsPayable
2493000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2674000
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
2764000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
726000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
1106000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
228000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
705000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-7423000
us-gaap Increase Decrease In Restricted Cash And Investments
IncreaseDecreaseInRestrictedCashAndInvestments
-6256000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
8897000
us-gaap Increase Decrease In Restricted Cash For Operating Activities
IncreaseDecreaseInRestrictedCashForOperatingActivities
6033000
CY2015Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
471020
CY2014Q3 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
345504
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
430856
us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
323539
CY2015Q3 us-gaap Interest Expense
InterestExpense
594000
CY2014Q3 us-gaap Interest Expense
InterestExpense
632000
us-gaap Interest Expense
InterestExpense
1782000
us-gaap Interest Expense
InterestExpense
1566000
CY2015Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1424000
CY2014Q3 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
1131000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3885000
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
3371000
CY2015Q3 us-gaap Inventory Net
InventoryNet
7566000
CY2014Q4 us-gaap Inventory Net
InventoryNet
7127000
CY2015Q3 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
34925000
CY2014Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
37116000
CY2015Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
135136000
CY2014Q3 us-gaap Labor And Related Expense
LaborAndRelatedExpense
128938000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
392766000
us-gaap Labor And Related Expense
LaborAndRelatedExpense
374277000
CY2015Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
10006000
CY2014Q3 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
9913000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
29972000
us-gaap Lease And Rental Expense
LeaseAndRentalExpense
29712000
CY2015Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1082291000
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1074123000
CY2015Q3 us-gaap Liabilities Current
LiabilitiesCurrent
180687000
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
183558000
CY2015Q3 us-gaap Long Term Debt
LongTermDebt
10000000
CY2014Q4 us-gaap Long Term Debt
LongTermDebt
10000000
CY2015Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10000000
CY2014Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
10000000
CY2015Q3 us-gaap Malpractice Loss Contingency Number Of Claims
MalpracticeLossContingencyNumberOfClaims
33
CY2015Q3 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
110567000
CY2014Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
132535000
CY2015Q3 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
18260000
CY2014Q4 us-gaap Marketable Securities Restricted Current
MarketableSecuritiesRestrictedCurrent
19805000
CY2015Q3 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
150564000
CY2014Q4 us-gaap Marketable Securities Restricted Noncurrent
MarketableSecuritiesRestrictedNoncurrent
138468000
us-gaap Minority Interest Decrease From Redemptions
MinorityInterestDecreaseFromRedemptions
768000
CY2015Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
13761000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-14877000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-22793000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-47439000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-39941000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
63330000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
57946000
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
12567000
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
12829000
us-gaap Net Income Loss
NetIncomeLoss
38167000
us-gaap Net Income Loss
NetIncomeLoss
38569000
CY2015Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10415000
CY2014Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10662000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
31680000
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
32067000
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
us-gaap Noncash Or Part Noncash Acquisition Fixed Assets Acquired1
NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1
39032000
CY2015Q3 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
4970000
CY2014Q4 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
441000
CY2015Q3 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
13163000
CY2014Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
12548000
CY2015Q3 us-gaap Number Of States In Which Entity Operates
NumberOfStatesInWhichEntityOperates
10
CY2014Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
14736000
us-gaap Operating Income Loss
OperatingIncomeLoss
46903000
us-gaap Operating Income Loss
OperatingIncomeLoss
47807000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
390500000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
34200000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
34200000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
34200000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
34200000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
34200000
CY2015Q3 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
219500000
CY2015Q3 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
10208000
CY2014Q4 us-gaap Other Accrued Liabilities Noncurrent
OtherAccruedLiabilitiesNoncurrent
10219000
CY2015Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
250443000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
236854000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
3377000
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-13588000
CY2015Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-4095000
CY2014Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-5946000
CY2015Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
28000
CY2014Q3 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
2035000
CY2015Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-6724000
CY2014Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-9707000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
-21809000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
449000
us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci For Sale Of Securities Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax
172000
CY2015Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-2657000
CY2014Q3 us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-3761000
us-gaap Other Comprehensive Income Loss Tax Portion Attributable To Parent1
OtherComprehensiveIncomeLossTaxPortionAttributableToParent1
-8670000
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Before Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
5584000
CY2015Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
56616000
CY2014Q3 us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
55365000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
173830000
us-gaap Other Cost And Expense Operating
OtherCostAndExpenseOperating
166803000
CY2015Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
15517000
CY2014Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
12472000
CY2015Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16737000
CY2014Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
16011000
CY2015Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
4550000
CY2014Q3 us-gaap Other Nonoperating Income
OtherNonoperatingIncome
3937000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
12902000
us-gaap Other Nonoperating Income
OtherNonoperatingIncome
12790000
CY2015Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
10035000
CY2014Q3 us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
10451000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
30850000
us-gaap Other Sales Revenue Net
OtherSalesRevenueNet
32136000
us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
CY2014 us-gaap Other Than Temporary Impairment Losses Investments Availableforsale Securities
OtherThanTemporaryImpairmentLossesInvestmentsAvailableforsaleSecurities
0
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
6995000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
15367000
us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
13913000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6502000
us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
6502000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
373000
us-gaap Payments To Acquire Businesses And Interest In Affiliates
PaymentsToAcquireBusinessesAndInterestInAffiliates
1675000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
5477000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
767000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38953000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
36727000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
49993000
us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
36947000
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6502000
CY2015Q3 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
15.75
CY2014Q4 us-gaap Preferred Stock Liquidation Preference
PreferredStockLiquidationPreference
15.75
CY2015Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
us-gaap Payments To Minority Shareholders
PaymentsToMinorityShareholders
768000
CY2015Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2152000
CY2014Q3 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2167000
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
6487000
CY2014Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2015Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2014Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
25000000
CY2015Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10761692
CY2014Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
10836659
CY2015Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10761692
CY2014Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
10836659
CY2015Q3 us-gaap Preferred Stock Value
PreferredStockValue
169305000
CY2014Q4 us-gaap Preferred Stock Value
PreferredStockValue
170494000
CY2015Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2488000
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
2260000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
333000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
3046000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
8231000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
6757000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
39601000
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
27641000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
39601000
us-gaap Proceeds From Sale Of Restricted Investments
ProceedsFromSaleOfRestrictedInvestments
27641000
CY2015Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
856078000
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
821792000
CY2015Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
526255000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
514744000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5474000
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
5001000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
449000
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
172000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
2299000
us-gaap Repayments Of Debt And Capital Lease Obligations
RepaymentsOfDebtAndCapitalLeaseObligations
1693000
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
12125000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
10651000
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8494000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7020000
CY2015Q3 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3631000
CY2014Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3631000
CY2015Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
359365000
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
343941000
us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">D</div><div style="display: inline; font-style: italic;">eferred Revenue </div></div></div><div style=" TEXT-ALIGN: left; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">&nbsp;</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;"></div></div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">Deferred revenue includes the deferred gain on the sale of assets to National Health Corporation (&#x201c;National&#x201d;), the non-refundable portion</div><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"> (10%) of CCRC entrance fees being amortized over the remaining life expectancies of the residents, and premiums received within our workers&#x2019; compensation and professional liability companies that are not yet earned. </div></div></div></div></div></div></div></div></div></div>
CY2015Q3 us-gaap Self Insurance Reserve
SelfInsuranceReserve
105933000
CY2014Q4 us-gaap Self Insurance Reserve
SelfInsuranceReserve
106218000
CY2015Q3 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
26754000
CY2014Q4 us-gaap Self Insurance Reserve Current
SelfInsuranceReserveCurrent
26825000
CY2015Q3 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
79179000
CY2014Q4 us-gaap Self Insurance Reserve Noncurrent
SelfInsuranceReserveNoncurrent
79393000
us-gaap Share Based Compensation
ShareBasedCompensation
1557000
us-gaap Share Based Compensation
ShareBasedCompensation
1547000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0273
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.0268
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.165
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.173
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0071
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.0052
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
187263
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
51.36
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
20000
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
46.69
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
57716
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
56792
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
0
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8231000
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
954678
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
835286
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.44
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
46.92
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
47.95
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
45.97
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
46.68
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
53.10
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
61.47
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P2Y73D
CY2015Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
1802000
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
157590
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
176184
us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
6756000
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
-6995000
CY2014Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
125000
CY2014Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
6995000
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
688112000
CY2014Q3 us-gaap Stockholders Equity
StockholdersEquity
710117000
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
734148000
CY2015Q3 us-gaap Stockholders Equity
StockholdersEquity
746357000
CY2015Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
14292000
CY2015Q3 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
2444000
CY2015Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
183000
CY2014Q3 us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
16000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
513000
us-gaap Unrecognized Tax Benefits Period Increase Decrease
UnrecognizedTaxBenefitsPeriodIncreaseDecrease
290000
CY2015Q3 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1715000
CY2014Q3 us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1542000
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1715000
us-gaap Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations
UnrecognizedTaxBenefitsReductionsResultingFromLapseOfApplicableStatuteOfLimitations
1542000
CY2015Q3 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
5239000
us-gaap Use Of Estimates
UseOfEstimates
<div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style="display: inline; font-family: times new roman; font-size: 10pt"><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif"><div style="display: inline; font-style: italic;">Estimates and Assumptions</div></div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">&nbsp;</div></div><div style=" TEXT-ALIGN: justify; MARGIN: 0pt; LINE-HEIGHT: 1.25; TEXT-INDENT: 36pt"><div style="display: inline; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman, Times, serif">The preparation of financial statements in conformity with accounting principles generally accepted in the United States requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates and could cause our reported net income to vary significantly from period to period.</div></div></div></div></div></div></div></div></div></div>
CY2015Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14422660
CY2014Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14236512
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14365251
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
14230031
CY2015Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13801245
CY2014Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13805430
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13778705
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13838891

Files In Submission

Name View Source Status
0001047335-15-000131-index-headers.html Edgar Link pending
0001047335-15-000131-index.html Edgar Link pending
0001047335-15-000131.txt Edgar Link pending
0001047335-15-000131-xbrl.zip Edgar Link pending
exhibit101creditagreement.htm Edgar Link pending
exhibit102pledgeandsecuritya.htm Edgar Link pending
exhibit103note.htm Edgar Link pending
exhibit311adams.htm Edgar Link pending
exhibit312daniel.htm Edgar Link pending
exhibit32nhc.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
nhc-20150930.xml Edgar Link completed
nhc-20150930.xsd Edgar Link pending
nhc-20150930_cal.xml Edgar Link unprocessable
nhc-20150930_def.xml Edgar Link unprocessable
nhc-20150930_lab.xml Edgar Link unprocessable
nhc-20150930_pre.xml Edgar Link unprocessable
nhcseptember2015form10q.htm Edgar Link pending
nhcseptember2015form10q001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending